Sinco Pharmaceuticals Holdings Ltd. engages in the marketing, promotion, and channel management services for pharmaceutical products and medical devices. It offers human albumin solution and antiobiotics such as Axetine and Medocef. It operates through the following segments: Sale of Imported Pharmaceutical Products, Research and Manufacturing of Aesthetic Medicine, and Medical Beauty Services. The company was founded on April 1, 2011 and is headquartered in Chengdu, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company